Pfizer spin-out SpringWorks Therapeutics has its first approved product after getting a green light from the FDA for Ogsiveo, the first-ever therapy for a rare type of non-cancerous tumour that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results